Agilent Technologies A is leaving no stone unturned to bolster diagnostic tool offerings in a bid to strengthen its Diagnostics and Genomics Group (DGG) segment. Notably, Agilent received FDA approval ...
Visit a quote page and your recently viewed tickers will be displayed here.
Agilent Technologies A received approval for its Resolution ctDx FIRST from the U.S. Food and Drug Administration (FDA). The approval is about utilizing ctDx FIRST as a companion diagnostic (CDx) in ...
Fintel reports that on June 4, 2025, Oppenheimer upgraded their outlook for Dollar General (BMV:DGG) from Perform to Outperform. There are 2,129 funds or institutions reporting positions in Dollar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results